» Articles » PMID: 14621070

Redox Balance in Patients with Down's Syndrome Before and After Dietary Supplementation with Alpha-lipoic Acid and L-cysteine

Overview
Specialty Pharmacology
Date 2003 Nov 19
PMID 14621070
Citations 3
Authors
Affiliations
Soon will be listed here.
Abstract

The aim of the present study was to investigate the possible normalizing effect of antioxidants on certain parameters indicative of oxidative stress in Down's syndrome (DS). The study was performed in pediatric patients with DS with proven redox imbalance, who were advised to take a dietary supplementation composed of alpha-lipoic acid and L-cysteine for several treatment cycles (one treatment cycle = 30 days dietary supplementation plus 30 days wash-out). Serum thiol groups, serum total and septic reactive oxygen species (ROS) and total antioxidant status of serum were determined before and after dietary supplementation, using commercially available kits. In all the evaluable patients (n = 20), after 3.8 +/- 1.1 treatment cycles, thiol group serum concentrations and total antioxidant status of serum significantly increased (p < 0.0001 for both parameters) in comparison with basal values, while serum total and septic ROS significantly decreased (p < 0.0001 for both parameters). On the basis of these results it is impossible to demonstrate the clinical effects of the biochemical normalization obtained in patients with DS after supplying alpha-lipoic acid and L-cysteine. These data suggest that delaying the clinical expression of redox imbalance in patients with DS might be feasible by normalizing their redox balance.

Citing Articles

Alpha-Lipoic Acid and Its Enantiomers Prevent Methemoglobin Formation and DNA Damage Induced by Dapsone Hydroxylamine: Molecular Mechanism and Antioxidant Action.

Espindola K, Varela E, de Albuquerque R, Figueiredo R, Santos S, Malcher N Int J Mol Sci. 2023; 24(1).

PMID: 36613503 PMC: 9820452. DOI: 10.3390/ijms24010057.


Antioxidants in Down Syndrome: From Preclinical Studies to Clinical Trials.

Rueda Revilla N, Martinez-Cue C Antioxidants (Basel). 2020; 9(8).

PMID: 32756318 PMC: 7464577. DOI: 10.3390/antiox9080692.


The exercise redox paradigm in the Down's syndrome: improvements in motor function and increases in blood oxidative status in young adults.

Aguiar Jr A, Tuon T, Albuquerque M, Rocha G, Speck A, Araujo J J Neural Transm (Vienna). 2008; 115(12):1643-50.

PMID: 18795225 DOI: 10.1007/s00702-008-0120-x.